We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+8.99%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
+$21.9B
(+100,205%)
Cap. Flow
-$417M
Cap. Flow
% of AUM
-1.9%
Top 10 Holdings %
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$89.3M |
| 2 |
Keysight
KEYS
|
+$86M |
| 3 |
Nike
NKE
|
+$78.3M |
| 4 |
Amphenol
APH
|
+$76.5M |
| 5 |
Comcast
CMCSA
|
+$72.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Celanese
CE
|
+$108M |
| 2 |
Monster Beverage
MNST
|
+$97.8M |
| 3 |
Starbucks
SBUX
|
+$79.7M |
| 4 |
Texas Instruments
TXN
|
+$67.3M |
| 5 |
Centene
CNC
|
+$64.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.83% |
| 2 | Financials | 13.42% |
| 3 | Healthcare | 13.25% |
| 4 | Industrials | 9.77% |
| 5 | Consumer Discretionary | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Digital Realty Trust
DLR
$71.5B
| $126K | ﹤0.01% |
1,067
+19
| +2% | +$2.34K |
|
1152
IQVIA
IQV
$40.5B
| $126K | ﹤0.01% |
817
-102
| -11% | -$14.9K |
|
1153
Canadian Imperial Bank of Commerce
CM
$109B
| $125K | ﹤0.01% |
3,026
-174
| -5% | -$7.36K |
|
1154
Cboe Global Markets
CBOE
$31.1B
| $124K | ﹤0.01% |
1,037
| – | – |
|
1155
Motorola Solutions
MSI
$73.1B
| $124K | ﹤0.01% |
771
-4
| -0.5% | -$659 |
|
1156
Douglas Dynamics
PLOW
$1.04B
| $124K | ﹤0.01% |
2,271
+620
| +38% | +$31.3K |
|
|
B
1157
DELISTED
Barnes Group Inc.
B
| $124K | ﹤0.01% |
2,021
+166
| +9% | +$9.6K |
|
1158
Pentair
PNR
$10.8B
| $123K | ﹤0.01% |
2,704
+561
| +26% | +$23.7K |
|
1159
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.08B
| $123K | ﹤0.01% |
1,908
| – | – |
|
|
WBK
1160
DELISTED
Westpac Banking Corporation
WBK
| $123K | ﹤0.01% |
7,249
-2,222
| -23% | -$40.2K |
|
1161
Healthpeak Properties
DOC
$15.7B
| $121K | ﹤0.01% |
3,539
+187
| +6% | +$6.54K |
|
1162
FirstEnergy
FE
$28.7B
| $121K | ﹤0.01% |
2,512
-449
| -15% | -$21.5K |
|
1163
Vanguard Mega Cap Growth ETF
MGK
$31.8B
| $121K | ﹤0.01% |
4,160
+2,660
| +177% | +$73.5K |
|
|
CSW
1164
CSW Industrials
CSW
$4.87B
| $120K | ﹤0.01% |
1,563
+63
| +4% | +$4.53K |
|
1165
Prestige Consumer Healthcare
PBH
$2.45B
| $120K | ﹤0.01% |
2,980
+80
| +3% | +$2.98K |
|
|
VPU
1166
Vanguard Utilities ETF
VPU
$8.68B
| $120K | ﹤0.01% |
845
-100
| -11% | -$14.1K |
|
1167
America Movil
AMX
$77.2B
| $119K | ﹤0.01% |
7,490
-800
| -10% | -$12.5K |
|
1168
Huntington Ingalls Industries
HII
$11.8B
| $118K | ﹤0.01% |
480
+7
| +1% | +$1.66K |
|
|
CY
1169
DELISTED
Cypress Semiconductor
CY
| $118K | ﹤0.01% |
5,105
-674
| -12% | -$15.8K |
|
1170
Moderna
MRNA
$22.1B
| $117K | ﹤0.01% |
6,000
| – | – |
|
1171
Royal Caribbean
RCL
$86.5B
| $117K | ﹤0.01% |
885
-36
| -4% | -$4.2K |
|
1172
Grupo Cibest SA
CIB
$21.1B
| $116K | ﹤0.01% |
2,134
+60
| +3% | +$3.1K |
|
1173
Myriad Genetics
MYGN
$502M
| $116K | ﹤0.01% |
4,277
-1,882
| -31% | -$51.8K |
|
|
PRO
1174
DELISTED
PROS Holdings
PRO
| $116K | ﹤0.01% |
1,940
+560
| +41% | +$32.3K |
|
1175
KKR & Co
KKR
$92.2B
| $115K | ﹤0.01% |
3,984
| – | – |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q4 2019 Portfolio in Review
As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
- Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
- Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
- Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
- Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
- Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
- Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.
Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.